TERT and melanoma: The frequency of mutations in the TERT promoter exceeds the frequency of any known noncoding gene mutations in melanoma [11], and the most common mutations in the TERT promoter (ATG start site −124C>T and −146C>T) are associated with increased TERT mRNA expression, telomerase activity, telomere length and poor prognosis [12].